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Abstract.  A  number of human cytokeratins are ex- 
pressed during  the development of stratified  epithelia 
from one-layered polar epithelia  and continue to be 
expressed in  several adult epithelial  tissues.  For 
studies of the regulation  of the synthesis of stratifi- 
cation-related  cytokeratins  in internal  tissues,  we have 
prepared  cDNA and genomic clones encoding cytoker- 
atin 4,  as a  representative  of the basic (type II) 
cytokeratin subfamily and cytokeratin  15, as representa- 
tive of the acidic (type I) subfamily, and determined 
their  nucleotide  sequences.  The  specific expression of 
mRNAs encoding  these two polypeptides in certain 
stratified  tissues and cultured  cell lines  is demon- 
strated by Northern  blot hybridization.  Hybridization 
in situ with antisense  riboprobes and/or  synthetic oli- 
gonucleotides  shows the presence of cytokeratin  15 
mRNA in all layers of esophagus,  whereas cytokeratin 
4  mRNA tends to be suprabasally  enriched,  although 
to degrees varying in different regions.  We conclude 
that the expression of the genes encoding these  stratifi- 
cation-related  cytokeratins  starts  already  in the basal 
cell layer and does not depend on vertical  differentia- 
tion and detachment  from the basal lamina.  Our re- 
sults also show that  simple epithelial  and stratification- 
related cytokeratins can be coexpressed in basal cell 
layers of certain  stratified epithelia  such as esophagus. 
Implications  of these findings  for epithelial  differentia- 
tion and the formation  of squamous cell carcinomas 
are discussed. 
PITHELIAL differentiation is usually characterized by 
the formation of intermediate-sized  filaments  (IFs) ~ 
of the cytokeratin type (20, 28, 85, 86). The early em- 
bryonal epithelia, i.e., ecto- and endoderm, are simple polar 
epithelia  and  possess IFs of the  most  simple polypeptide 
composition,  i.e.,  one representative of the acidic (type I) 
subfamily, i.e., cytokeratin 18, and one representative of the 
more basic (type II) cytokeratin subfamily, i.e., cytokeratin 
8 (17, 42, 43, 48, 55, 70). When during the development of 
certain organs the organization of one-layered polar epithelia 
changes and transforms to stratified epithelia,  the synthesis 
of other cytokeratins,  i.e.,  cytokeratins  1-6 and 9-17,  is in- 
duced; these appear to be related to the stratification process 
(for early embryonal epithelia see references 3,  13, 55, 68, 
92).  Among  the  earliest  stratification-related  cytokeratin 
polypeptides are cytokeratin 4, a type II polypeptide, and the 
type I cytokeratin  15, which are expressed during  the em- 
bryonic development  of all  the  diverse  stratified  epithelia 
studied  so  far,  including  epidermis  (68).  Cytokeratin  4 
seems to disappear in later stages of epidermal maturation, 
whereas  cytokeratin  15  expression  is  continued  in  adult 
epidermis where it persists as a minor component (11, 30, 65, 
1. Abbreviations used in this paper:  IF,  intermediate-sized filament: pfu, 
plaque-forming unit. 
68,  73).  While  cytokeratin 4  is one of the most abundant 
cytokeratins in several adult nonepidermat stratified epithelia 
such as oral and lingual mucosa, laryngeal and pharyngeal 
epithelia,  epiglottis, esophagus, exocervix, and vagina and 
in squamous cell carcinomas derived from these tissues (4, 
5,  31, 35, 65-69,  72, 73, 94), cytokeratin  15 is usually de- 
tected in these epithelia only as a minor component. 
Recent  immunocytochemical  studies  using  monoclonal 
antibodies specific for the stratification-related  cytokeratins 
4 and 13 have localized these proteins to the suprabasal layers 
of various stratified epithelia (91), suggestive of a correlation 
of these two cytokeratins with the vertical differentiation pro- 
cess. In this respect, information about cytokeratin 15 is to- 
tally lacking as so far no antibody specific for this protein 
has been described. In order to learn more about the regula- 
tion  of  the  selective  appearance  of  stratification-related 
cytokeratins in different tissues as well as in different layers 
of the same epithelial  tissue it was obviously necessary to 
have the adequate nucleic acid probes. So far human DNA 
clones are available only for some cytokeratins expressed in 
epidermis (e.g., 36, 37, 61, 82, 88) and certain simple epithe- 
lia (34,  56,  71,  80).  In the present  study,  we describe the 
cloning of genes encoding cytokeratins 4  and  15 and their 
amino acid sequences, and show their specific expression in 
various squamous epithelial tissues and cultured cell lines. 
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Tissue Preparation 
Tissue samples were obtained during surgery for various indications (Sur- 
gery  Clinics,  Women's Hospital,  and  Dermatology Department,  Mann- 
helm,  and  University of Heidelberg-Mannheim Medical  School).  Small 
pieces of epithelium were frozen in liquid nitrogen or in isopentane pre- 
cooled in liquid nitrogen to -130~  within 15 min after surgical removal, 
For RNA extraction epithelial cell layers were either quickly peeled off with 
forceps or scraped off with a scalpel. The collected epithelial material was 
either  frozen  in  liquid  nitrogen  or  immediately  homogenized  in  4  M 
guanidinium isothiocyanate  buffer (in 0.1  M Tris-HC1,  pH 7.5, 10 mM di- 
thiothreitol, (DTT),  and 5 mM EDTA). 
Library Screening and DNA Sequencing 
A cDNA library  in Lgtl0  constructed from poly(A)+-RNA of the vulvar 
carcinoma cell line A-431 was kindly provided by Dr.  A.  Ullrich (Genen- 
tech, South San Francisco, CA; cf. 90). A genomic library in European Mo- 
lecular Biology Laboratory  (EMBL)-3 phage constructed from partially 
digested human blood was kindly obtained from Dr.  R. Cortese (EMBL, 
Heidelberg, Federal Republic of Germany (FRG);  cf. 7).  Screening and 
DNA extraction procedures were performed essentially as described (56). 
As nick-translated screening probe we used a mixture of combined cDNA 
inserts excised from various bovine type I and II cytokeratin cDNA clones, 
including pKBla, pKBlb/c, pKBIII, pKBIV, pKBVI, pKBVll, pKB8 I, and 
pKBI9 ~ (2,  45-47,  60).  120,000 phages were plated from the amplified 
cDNA library.  The EcoRl  inserts of the purified phage DNAs were sub- 
cloned  into  the  pTZI8  R  vector  (Pharmacia,  Uppsala,  Sweden).  Both 
strands of the clones pKH4 ~ (encoding cytokeratin 4) and pKHI5 t (encod- 
ing cytokeratin  15) were sequenced according to the standard protocol of 
Maxam and Gilbert (62).  The nick-translated Y-specific Xhol fragment of 
clone pKHI5 ~ was subsequently used to screen  1.2  ￿  106 phages of the 
genomic library.  Fragments of one of the three selected genomic clones 
(~.KH152) were  purified,  subcloned into  the  transcription vectors Blue- 
scribe and Bluescript (Stratagene, San Diego, CA), and sequenced. 
Construction of  a Y-specific Subclone and 
In Vitro Expression of  a Reconstructed Complete 
cDNA Clone for Cytokeratin 15 
Two polynucleotides of 75 residues, taken from both strands of the 3'-non- 
coding  region  (residues  1606-1680;  see  Results),  were  synthesized and 
purified as described (57),  attached to EcoRI  linkers and cloned into the 
transcription vector Bluescript (clone pKH152). For the construction of a 
complete hybrid cDNA clone encoding cytokeratin 15, the KpnI/Kpnl  frag- 
ment of 479  nucleotides of the genomic phage clone ~,KHI52 which con- 
tains a large part of the first exon was ligated to the unique Kpnl site of the 
cDNA clone pKHI5 ~. The BamHI/EcoRI  insert of this clone was further 
subcloned into Bluescript (clone pKH15~). The transcript of pKHI53 ob- 
tained with T7  RNA-polymerase was translated in vitro (cf. 59)  and the 
translational product was analyzed by coelectrophoresis with cytoskeletal 
proteins from A-431 cells or tissues (cf.  53,  60,  65). 
RNA Preparation and Northern Blot Analysis 
Total RNA and poly(A)+-RNA were extracted from cultured human cells 
of the  vulvar  epidermoid carcinoma-derived cell  line  A-431,  including 
clonal sublines expressing cytokeratin 4 as well as clones with high relative 
contents of either cytokeratin 13 (clone E3) or cytokeratin 15 (clone E6; for 
different sublines, see also reference 65),  the breast carcinoma cell  line 
MCF-7,  the pharyngeal carcinoma-derived cell line Detroit-562,  and the 
bladder carcinoma-derived cell line RT-112 (65,  66, 73).  For comparison, 
RNA  from SV40-transformed human fibroblasts (27)  was used.  Culture 
dishes were rinsed three times with PBS. After carefully decanting the buf- 
fer, the cells were directly suspended in the 4 M guanidinium isothiocyanate 
buffer (see above), scraped off, and homogenized with an Ultra Turrax blen- 
der (Janke and Kunkel KG, Staufen,  FRG).  RNA was extracted from homog- 
enates of cultured cells and from tissue samples essentially as described 
(56). Poly(A)+-RNA was bound to an oligo-dT cellulose matrix and eluted 
as described by  Kreis et al.  (53).  Purified RNA was electrophoretically 
separated on 1.2 % agarose gels containing formaldehyde, blotted onto Gene 
Screen Plus and hybridized with RNA polymerase in vitro transcripts (56). 
Hybrid Selection and Translation In Vitro 
Poly(A)+-RNA from A-431 cells (clones E3 and E6) or total  RNA  from 
Detroit-562 cells were hybridized to filter-bound subclones and selected 
mRNAs were translated  in  vitro using  [35S]methionine  as label  (cf. 46, 
60).  In experiments with the  short subclone pKHI52,  the hybridization 
temperature was lowered to 32~  and the bound RNA was successively re- 
moved by  washes at  increasing temperature.  Two-dimensional gel elec- 
trophoresis was performed as coelectrophoresis of the in vitro translation 
products with an excess of unlabeled reference proteins and cytoskeletal pro- 
teins from A-431 cells or from esophageal tissue to allow the identification 
of the translational products (cf. 46,  58, 60,  65). 
Hybridization In Situ 
Upon linearization of pKH4 ~ with HindIII  and  pKHl51  with BglI ribo- 
probes were obtained that could be radioactively labeled by in vitro tran- 
scription with T7 RNA polymerase (56). The 75-mer polynucleotide com- 
plementary  to  residues  1606-1680  (see above)  was  5'  end-labeled with 
[~,-32P]ATP using polynucleotide kinase and purified (cf. 57).  The protocol 
for hybridization in situ was as described (9, 56).  Posthybridization treat- 
ment with RNase A  was omitted when synthetic oligonucleotide probes 
were used. 
Immunofluorescence Microscopy 
4-5  Ixm cryostat sections of various  tissues,  including esophagus,  epi- 
dermis, endo- and exocervix, vagina, tongue, lung, liver,  and colon were 
processed as described (cf.  1).  Monoclonal antibody 6BI0,  specific for 
cytokeratin 4 (91) was kindly provided by Dr. G.  van Muijen (University 
of Leiden, Netherlands). 
Results 
Immunocytochemical Localization 
of Stratification-related C  ytokeratins 
in Internal Epithelia 
Most internal squamous stratified epithelia are characterized 
by abundant amounts of cytokeratins 4 and 13, together with 
usually lesser amounts of cytokeratins 5, 6,  14, and  15 (cf. 
73).  In immunofluorescence microscopy, monoclonal anti- 
bodies specific for cytokeratins 4 and 13 stain, in the epithelia 
studied so far, all suprabasal cell layers rather uniformly but 
leave the basal cell layer unstained. For example, Fig.  1, a 
and b shows the reactivity of  the cytokeratin 4-specific mono- 
clonal  antibody 6B10 on  esophagus,  and  similar  pictures 
were also obtained with other stratified tissues (not shown) 
such as exocervix (cf. 22), vagina, oral, and lingual mucosa 
(e.g., 72).  Remarkably, cytokeratin 4-specific immunostain- 
ing is not restricted to the stratified epithelium but positive 
reaction can also be seen in certain cells or cell clusters in 
the ducts of mucous and serous glands of the esophageal sub- 
mucosa (Fig.  1, c and d; cf. 40). As antibodies specific for 
cytokeratins 5, 6, 14, or 15 are not available the tissue distri- 
bution  of  these  cytokeratins  in  internal  epithelia  is  not 
known. 
Isolation of  cDNA Clones Encoding 
Human Cytokeratins 
A ~,gtl0 cDNA library of the cell line A-431 was initially cho- 
sen because these cells  coexpress a  total of up  to eleven 
different cytokeratins (65,  73),  including cytokeratins 5, 6, 
13-15, and at least in some sublines, small amounts of cyto- 
keratin 4 as well (unpublished data; 91). 1.2  ￿  105 plaque- 
forming units (pfu) of the amplified library were screened 
with a mixed probe containing the nick-translated inserts of 
The Journal  of Cell Biology,  Volume 106, 1988  1250 Figure L Immunofluorescence microscopy of frozen sections of human esophagus and its submucosal glands after reaction with monoclonal 
antibody 6Bt0 specific for cytokeratin 4.  The same field  is shown in epifluorescence (a, c) and phase-contrast (b, d) optics. L, lumen; 
E, epithelium; LP, lamina propria. (a, b) Intense immunofluorescence of suprabasal cell layers, whereas the two to three basalmost cell 
layers, forming the basal compartment C1 (brackets;  the broken line in b denotes the basal lamina), are unstained.  (c, d) Heterogeneous 
reaction of certain groups of cells in the duct epithelium of an esophageal gland. Most of the positively stained cells are adluminat.  Bars, 
50 ~tm. 
diverse  bovine cDNA  clones  (see Materials  and  Methods) 
under  low  stringency  conditions.  19  phages  were  plaque- 
purified and  11  of them were confirmed as containing  cyto- 
keratin-positive clones by Southern blot hybridization.  Hy- 
bridization  with clones pKH8 ~ and pKH182 under  stringent 
conditions,  in addition to restriction enzyme mapping, iden- 
tified three phage clones as positive for cytokeratin 8 and four 
clones positive for cytokeratin 18 (cf. 56 and 71). The inserts of 
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were integrated  into the  transcription  plasmid pTZ  18R. 
Identification  of a cDNA Clone Encoding 
Human Cytokeratin 4 
After  hybridization  with  RNA  from  A-431  cells,  the  sub- 
clone  pKH4 ~ selected  a  mRNA  which  yielded,  on  release 
and  in  vitro translation,  a  barely detectable  product  which 
did not comigrate with any of the major cytokeratins present 
in  A-431  cells  (data  not  shown).  However,  a  hybrid  selec- 
tion-translation  experiment  with  RNA  from  Detroit-562 
cells  revealed  a  distinct  translational  product  which  comi- 
grated with  authentic  cytokeratin 4  (Fig.  2,  a  and  b). 
When  RNA  extracted  from diverse  tissues  and  cultured 
cell  lines  was probed  for mRNA encoding cytokeratin 4  in 
Northern  blot  hybridization  experiments,  using  specific 
riboprobes derived  from clone pKH4  r (for details,  see Fig. 
3),  all those tissues  and cells  in which  this  cytokeratin had 
been found by immunocytochemistry and/or gel electropho- 
resis were also positive in this test (Fig. 2, c-e). In contrast, 
epithelial  cell  cultures  as  well as  simple (colon)  and  squa- 
mous stratified  (epidermis)  epithelial  tissues,  in which  this 
cytokeratin has not been detected at the protein  level, were 
negative in Northern blot hybridization with this probe (Fig. 
2,  c-e).  These results also show that,  under our stringency 
conditions  of hybridization,  cross-hybridization  with mRNAs 
for other cytokeratin members of the same subfamily did not 
occur,  thus  allowing the specific detection  of cytokeratin 4 
mRNA (cf.  46;  see,  however,  32,  49). 
The by far highest concentration of mRNA for cytokeratin 
4  was found  in esophageal  RNA  (Fig.  2  c,  lanes  4  and  4'; 
Fig.  2  d,  lane  10).  When  cultured  cells  were  probed  for 
cytokeratin,  two  of the  carcinoma  cell  lines  derived  from 
stratified  tissues,  i.e.,  pharyngeal  carcinoma  line  Detroit- 
562 and the bladder carcinoma-derived line RT-112,  showed 
mRNA signals of moderate intensity  (Fig.  3 c,  lanes 2' and 
3', and 3 d, lane 7), whereas only a weak signal was obtained 
with RNA from A-431 cells from which the cDNA clone was 
isolated (Fig.  2 d, lanes 8 and 9).  This seems to be in agree- 
ment with  biochemical  findings of only miniscule  amounts 
of cytokeratin 4  in  this  cell  line  (cf.  65,  91). 
Sequence Characteristics of Human Cytokeratin 4 
Sequencing  shows  that  the  1760-bp  insert  of clone  pKH4 ~ 
offers an open reading frame encoding 408 amino acids (Fig. 
3) and a 3'-noncoding portion of 536 bp which contains a ca- 
Figure 2.  Identification and characterization of clone pKH4  ~  as coding for human cytokeratin 4 by hybrid selection and translation (a, b) 
or Northern blot hybridization analysis (c-e). (a, b) Hybrid-selection experiment in which total RNA from cultured human Detroit-562 
cells have  been exposed to clone pKH4 ~,  showing  the  in vitro translated  product of the specifically bound  mRNA to comigrate with 
authentic cytokeratin 4 of a cytoskeletal  preparation of esophagus. (a) Coomassie Blue-stained  polypeptides separated by two-dimensional 
gel electrophoresis (in a, the direction of nonequilibrium pH-gradient electrophoresis in first dimension is from right to left and the second 
dimension SDS-PAGE  is from top to bottom, as indicated  by arrows in the upper right corner) include  the major esophageal cytokeratins 
4,  5, 6, and  13,  reference proteins (bovine serum albumin, B, and  a-actin,  0t) and an endogenous component of the rabbit reticulocyte 
lysate  system used  for in  vitro  translation  (arrow).  (b) Autoradiograph  of the  gel  shown  in  a,  revealing the  [3~S]methionine-labeled 
cytokeratin 4, and a slightly more acidic degradation product, as the only labeled polypeptides. (c-e) Autoradiographs of different Northern 
blots hybridized with  antisense riboprobes for the 3'-noncoding sequence of clone pKH4 ~ (see Materials and Methods).  20 p_g of total 
RNA was loaded on the gel in c, whereas  10 ~g of total  RNA was applied in d and e, with the exception of lanes 8 (5 ~tg of POly(A)*- 
RNA) and 9 (50 pg of poly(A)+-RNA). RNA was from SV-40-transformed  fibroblasts  (lanes 1, 1', and 5), the pharynx carcinoma-derived 
cell  line Detroit-562  (lanes 2, 2', and  7), the bladder carcinoma-derived cell line RT-112 (lanes 3 and 3'),  human esophagus (lanes 4, 
4', and 10; in the overexposed lanes, reactivity with degraded RNA is more prominent), the breast carcinoma cell line MCF-7 (lane 6), 
the vulvar epidermoid carcinoma-derived cell  line A-431  (lanes 8 and  9),  human colon mucosa (lane 11), and adult epidermis (lanes 
12). Prolonged autoradiographic exposure of lanes 1-4 is shown in lanes  1'-4'.  Bars on the left margin indicate  the positions of (from 
top to bottom) the 28 S, 23 S,  18 S, and  16 S rRNAs coelectrophoresed as markers. The size of the mRNA encoding cytokeratin 4 was 
estimated to be ~2.2  kb.  We cannot satisfactorily explain the different signal  intensities  in lanes 2, 2', and  7;  perhaps they are due to 
different RNA transfer efliciencies, 
The Journal of Cell Biology, Volume 106, 1988  1252 1  T~CTc~`~A~TTG~T~A~TC~A~GTG~TTGA~TGAGAT~AGAAAGTCCGGACGGAAGAGCGCGAACAGATCAA'~ 
1SLNQSLLTPLHVEIDPEIQKVRTEEREQIk 
~I  ~T~T~C~AAGTTT~T~TT~AT~GGT~GTT~TTA~GC~AGAATAAGGTC~TGGAGACCAAATGGAACCT'3C~rC 
31LLNNKFASFIDKVQFLEQQNKVLETKWNLL 
151  ~A~A~A~A~A~T~A~AAAAA~TT~T~TTTGAGACCTACCTCAGTGT~TGAGGAAGCAGCTAGATACCTTG 
51Q~QTTTTSSKNLEPLFETYLSVLRKQLDTL 
271GGC~T~CAAAGGGCGCCTGCAGTCT~TGAA~CCAT~AG~CAGCGTGGAGGACTTC~CT~GTAT~AGAGGAGATC~C 
~IGNDKGRLQSELKTMQDSVEDFKTKYEEEIN 
3~1  ~CGCA~GCA~C~GAAT~CTTTGT~TCCTAAAGAAGGACGTG~TGCT~CTACCT~AC~GGTG~GTTGGAGGCCAAGGTG 
121KRTAAENDFVVLKKDVDAAYLNKVELEAKV 
451  ~CAGT~TT~T~GAGATC~TTC~TGAA~TCCTCTAT~T~GGAGCTGTCC~A~TGCA~ATGT~AG~GA~A~GTCCGTG 
151DSLNOEINFLKVLYDAELSQMQTHVSDTSV 
541  GTcCTTTC~TGGAcAACAACC~TGGACCTGGACA~ATTATTGCC~GGTCCGTG~CCAGTAC~G~GATTGCCCAGAGGA~ 
131VLSMDNNRNLDLDSIIAEVRAQYEEIAQRS 
831  ~GGCT~GGCTGAA~CCTGTAC~CC~TCCA~A~TCCA~TCTC~TT~CC~CATGGT~C~CCTGAAGAACACCAAG 
211KAEAEALY~TKVQQLQISVDQHGDNLKNTK 
721AGTGAAATTGcA~Tc~cAGGAT~TccA~GC~CT~GGGCA~TC~GAACATC~GAAGCAGTGCCAGA~TCTTCA~TATCC 
2415EIAELNRMIQRLRAEIENIKKQCQTLQVS 
311  GTGGCT~T~A~GCA~T~GAAT~CCTTAAA~T~CCACAGC~GCGTAGAGCTGGAGGCTGCCCTGCAGCAGGCC~G 
2?IVADAEQRGENALKDAHSKRVELEAALQQAK 
~01GAGGA~TGGcA~C~`AT~T~GT~GTAC~GGA~TCAT~GTGTGAA~GG~CTTGGACATC~GAT~GCCACCTACCGCAAACTG 
301  E  E  L  A  R  M  L  R  E  Y  Q  E  L  M  S  V  K  L  A  L  D  I  E  I  A  T  Y  R  K  L  ~gure  3. Nucleotide sequence  of 
g91  CTGGAGGGC~GGAGTAcAGAATGTCTGGAGAAT~GT~CGTGA~ATCT~TGTGGTCAGC~TA~A~CAG~ACTG~GG~ATC  clone  pKH4'  and  the  deduced 
331  L  E  G  Er  E  V  ,  U  S  a  E  C  ~  S  A  V  S  ,  S  V  V  S  G  S  T  S  r  G  a  ~  na~ial  amino  acid 
of  sequence 
1081A~GGAGGAT~AGGAA~GGc~GGG~GGC~G~AGTG~GGC~CTGGAAG~GG~TTG~TTTGG~CAG~G~  human cytokeratin  4  (one letter 
3815GGLGSGSGFGLSSGFGSGSGSGFGFGGSV  code).  The end of the e-helical 
1171  ~c~GG~A~TTC~AGCA~~TcTA~CACCA~GAAc~GAGA~GATAGAG~GAc~GGT~cTG~AG~TCACTGT~T~A  coil~-coil domains is demarcated 
391  $  G  S  S  S  S  K  I  I  G  T  T  T  L  N  K  R  R  i  hv 
Asterisk shows the  an arrow. 
,2el  ~TGGGcccA~A~G~c~c~cc~TcAc~cAcc~ccA~cc~c~G~c~c~c~cA~c~A~AG~ccccTccAC~A  stop codon. The polyadenylation 
1351  TC~CA~GGGCTC~T~cC~GGA~T~G~GGGA~AGGGACT~C~C~G~TGG~AGCTA~T~GAT~GGG  signal  15 bp  upstream  from the 
1441  cC~cc~Acc~GGAA~GGGAAGGATGTcA~C~cACcTCcCA~GcA~Ga`AGAAAATGACCAG~GTGTcATCTcCAG  poly(A)-tail  is  underlined.  The 
~ndllI  site used  ~r  truncation 
1531  ~TATTGGGG~A~A~ATGT~T~AGTC~A~C~CA~A~TGTA~AT~ATC~ACAT~AG~AAACTA~T~  prior to  in  vitro  transcription 
1521  ~Tc~GGCA~AcTTGGC~TG~AA~T~AG~G~A~AG~GTC~ATT~AC~TC~A~C~A~A~  ~r  preparing  the  riboprobe  is 
1711T~A~TGAATCTTC~T~T~TTTTGTCATTCAAAAAAAAAAA~A  overlined. 
nonic polyadenylation site and,  15 bp further downstream, 
an uninterrupted stretch of 14 adenosine residues, apparently 
the  residue  of the  poly(A)-region.  Sequence  comparison 
with other IF proteins identified theeneoded protein as a typ- 
ical member of the basic (type II) subfamily of cytokeratins 
(cf. 37). Conformation prediction analyses (for programs ap- 
plied see 2, 79) revealed the typical organization into central 
a-helical regions flanked by non-a-helical head and tail do- 
mains  (cf.  Fig.  4).  The three highly conserved helical re- 
gions (la,  lb, and 2) are characterized by a typical heptad 
pattern, which is interrupted by short spacer sequences, indi- 
cating that these regions form stable coiled-coil complexes 
with complementary cytokeratins (for reviews see 36, 37, 84, 
93).  The sequence demarcating the abrupt transition from 
H  ~.  Cla  Clb 
......  "1-  ￿9  F  ￿9  ￿9 
H  ￿9  sLNQ~LLTPLHVE~DPE~Q4~TEE~EQ~KLLNNKFA~F~DKVQFLEQQNKVLETK~NLLCK~QTTTTSSKNLEPLFETYLSVL~KQLDTL 
MKS7  T~NQSLLT~LQvE~DPE~QK~RTAE~EQ~KTLNNKFASF~DK~RFLEQQNK~LETKw~LL~CK~TTTr~K5LD~FFET~HALRKNLDTL 
c~b  ......  ":1 
H  4  GNDKGRLQSELKTMQOSVEOFKTKYEEEINKRTAAENDFVVLKKDVDAAYLNKVELEAKVDSLHDEtNFLK  VLYDAELS~dQTHVSDTSV 
k/dKS7  sNDKGRLQSELKMM~DSvE~FKTKYEEE~NK~TAAENDF~VLKKDvDAAYM~K~ELEAKME~LKDE~NFTRvLYEAELAQM~THv~DTSv 
F 
￿9  I  Y  R  KA  A  LY  TKV  INV  H  4  VLSMONNRNLDLDS  IAEVR  Q  EEIAQ  S  E  EA  O  "  QQLQ  .  DQHGDNLKNTKSEIAELNRMIORLRAEIENIKKQCQTLQVS 
MKS7  VL~MDNNRNLDLDG~AE~AQYED~ARKSKAEVES~YQ~KvQ~LQ~dSADQHGDSLKTTKNE~SELNRM~QRLRAE~ENiKKQSQTPQAS 
--  C2  ....  G"IE  T 
H  4  VA~AEQRGENALKDAHSK~VELEAALQQAKEELARMLREYQELMSVKLALDIEIATY~KLLE  EYRMSGECQ~AVSIS~VSG~TSTGGI" 
IdIKSl  vADAEQRGELALKDAYSKRAELETALQKAKEDLARLLRDYQALM~VKLALDVE~ATYRKLLEGEECRM~GECKSA~S~S~vGGSQH--~w 
T 
H  4  SGGLGSGSGFGLSSGFGSGSGSGFGFGGSVSGSSSSKIIS--TTTLNKRR 
MK57  RSGLGLGSGFCS  ....  GSGSGSGFGFGGGIYGGSGSKITSSATITKRSPR 
Figure  4.  Comparison  of  the 
amino  acid sequence  of human 
cytokeratin 4 (H 4) with that of 
the murine Mr 57,000 cytokera- 
tin  (MK57;  51).  Asterisks  show 
identical  residues,  numbers  de- 
note  conservative exchanges:  1 
(for S and T), 2 for acidic amino 
acids (D and E), 3 for basic resi- 
dues (H, R, K), and 5 for hydro- 
phobic residues  (M, I, L, V, A). 
The coiled-coil  rod domain is di- 
vided  into  a-helical  coils  Cla, 
Clb,  and C2 which are flanked 
by  an  incomplete  head  domain 
(H) and the tail region (T). Note 
the  high  degree  of  homology 
(~85 %) of amino acid sequences 
of the polypeptides which is not 
restricted to the rod domain but 
also extends  to the head and the 
tail regions. 
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TYR(X)LLEG present in all IF proteins (32,  36,  37, 73,  84, 
93).  Comparisons  with  other  protein  sequences  identified 
the  murine  Mr  57,000  (mol  wt  56,429)  cytokeratin,  ex- 
pressed  predominantly  in  tongue  and  forestomach  (51),  as 
the  protein  most  closely  related  to  pKH4 ~ (Fig.  4).  The 
amino acid identity of ~80%  between human cytokeratin 4 
and  this  murine  cytokeratin  was  considerably  higher  than 
that with human cytokeratin 6 (65 %; 37, 88),  indicating that 
the  mouse Mr  57,000  cytokeratin  may be the  equivalent  to 
human  cytokeratin  4.  None  of the  various  bovine  type  II 
cytokeratin sequences determined  in our laboratory (cf. 45, 
47,  58)  showed  a  similarly  close  relationship  to  human 
cytokeratin 4. 
The tail region of human cytokeratin 4 is exceptionally rich 
in hydroxyamino acids (40%) but contains  less glycine resi- 
dues  and  glycine-rich  oligopeptide  repeats  than  several 
epidermal  type II cytokeratins  (37,  45,  82).  The conserved 
sequence motif of the basic heptapeptide DGKvLVS~ present 
in many IF proteins (19, 29, 44, 45,  56,  58,  73,  80;  see also 
below) is absent in both human cytokeratin 4  and its murine 
equivalent.  The carboxyterminus is very basic, as in several 
other  type II cytokeratins  (e.g.,  45). 
Figure 5. Identification of cDNA clones coding for human cytokera- 
tin  15.  (a, b) Hybrid selection-translation of poly(A)+-RNA from 
cells of the A-431 subline E3 as obtained after hybridization to the 
cDNA  clone  pKH15 ~.  (a)  Coomassie  Blue-stained  cytoskeletal 
proteins of A-431 cells (line  E3) separated by two-dimensional gel 
electrophoresis (arrows as in Fig. 2 a), together with proteins of the 
translational assay, coelectrophoresed with reference protcins (as in 
Fig.  2 a). The major cytokeratins 5, 8,  13, and  18 are denoted; the 
arrow indicates  the major endogenous component of the reticulo- 
cyte lysate system. (b) Autoradiograph corresponding to a. The ma- 
jor [35S]methionine-labeled  product of the  in  vitro translation  of 
mRNA selected by pKH15 ~  comigrates with authentic cytokeratin 
13.  (c-f) Two-dimensional gel electrophoresis (horizontal  arrow, 
direction of isoelectric focusing used in first dimension; downward 
arrow, direction of second dimension SDS-PAGE)  of the polypep- 
tides synthesized in vitro by transcription of the reconstructed com- 
plete cDNA clone pKHI53 and subsequent translation of the RNA 
obtained with cytoskeletal proteins from A-431 cells of line  E3 (c. 
d)  or E6 (e, f).  (c)  Coomassie Blue  staining  showing  the  major 
cytokeratins 8,  13,  14,  and  18 and  residual  D- and ),-actin  (A) of 
A-431 cells. The arrow denotes the position of cytokeratin 15 which 
is only a miniscule cytokeratin in this cell line.  (d) Autoradiograph 
of the gel shown in c, showing that the polypeptide synthesized from 
clone pKH153 in vitro comigrates with cytokeratin 15 and not with 
cytokeratin 13. (e) Coomassie Blue staining  of cytoskeletal  proteins 
of A-431 subline E6 rich in cytokeratin 15 and poor in cytokeratin 
13. (f) Autoradiograph of the gel shown in e, showing the comigra- 
tion  of the  polypeptide  synthesized  from clone  pKHI53  in  vitro 
with cytokeratin 15 and not with cytokeratin  13.  (g, h) Hybrid se- 
lection-translation of poly(A)+-RNA from cloned A-431 cells (line 
E6)  hybridized  to  the  3'-end-specific cDNA  clone  pKH152 (see 
Results).  (g) Coomassie Blue-stained polypeptides (as in e). (h) Au- 
toradiography  corresponding  to  g,  showing  the  product  of the 
mRNA  from  A-431 cells  (clone  6)  specifically  selected  by  the 
3'-specific subclone pKHI52, the cytoskeletal proteins of clone 6 of 
A-431 (same denotations as in e) together with endogenous compo- 
nents  of the  reticulocyte lysate system as detected by Coomassie 
Blue staining.  (h) Corresponding autoradiograph  to g. The [35S]me- 
thionine-labeled product of the in vitro translation comigrates with 
authentic cytokeratin  15 and not  with cytokeratin  13. 
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Encoding Human Cytokeratin 15 
When  the  cDNA  clone  pKH15 ~ and  the  reconstructed 
cDNA clone pKH153 were used in hybrid selection-transla- 
tion experiments with RNA from A-431 cells of clone E3 it 
specifically selected a mRNA that was translated in vitro into 
a  polypeptide  comigrating  with  authentic  cytokeratin  13 
(e.g., Fig. 5, a and b). However, results obtained in Northern 
blot hybridizations, notably with epidermal mRNA, and in 
mRNA hybrid-release experiments with certain clonal A-431 
sublines containing lower amounts of cytokeratin 13 but large 
amounts of cytokeratin 15 such as clone E6 were incompati- 
ble  with  the  interpretation  of  a  cytokeratin  13-encoding 
cDNA (data not shown; see also below). For an unequivocal 
identification of these cDNA clones we therefore used clone 
pKH153 for in vitro synthesis of the corresponding mRNA 
and polypeptide which was then found to comigrate, in gel 
electrophoresis, with cytokeratin 15 and not with cytokeratin 
13 (Fig. 5, c-f, presents results from two different A-431 sub- 
lines, E3 and E6). This indicated that the protein encoded by 
this clone is in fact cytokeratin 15 and that cytokeratins 13 and 
15 are very closely related. To examine this interpretation we 
synthesized a  polynucleotide of 75  residues located in the 
3'-noncoding region, i.e., the region showing the highest se- 
quence divergence within the type I  cytokeratin multigene 
family (46,  47,  74,  79).  This probe (pKH152) allowed the 
distinction between cytokeratins 13 and  15 as demonstrated 
in the hybrid selection experiment shown in Fig. 5, g and h. 
Northern  blot  experiments  identified  a  cytokeratin  15 
mRNA of,~l.9 kb in A-431 cells (Fig. 6, lanes 1 and 7) and 
in  certain  stratified epithelial  tissues,  including  epidermis 
(Fig. 6, lane 3) and esophagus (Fig. 6, lane 8). Only a very 
weak signal  was obtained in cultured cells of the line Detroit 
562 (Fig. 6, lane 6) whereas simple epithelia and various cell 
lines derived therefrom were negative (e.g., Fig. 6, lanes 2, 
5,  and  9). 
Sequence Characteristics of  Human Cytokeratin 15 
The  '~l.3-kb  insert  of the  cDNA  clone  pKH15 ~ extends 
from within coil  la to the 3'-end,  including a  short poly-A 
stretch.  A  3'-specific,  nick-translated  fragment  of  ~450 
nucleotides  of  this  clone  was  used  to  screen  a  human 
genomic  library.  The  isolated  phage  clone  ~,KH152 con- 
tained the  complete gene encoding human  cytokeratin  15. 
Nucleic acid sequencing proved the identity of the cDNA and 
the  genomic clone.  The  nucleic  acid  sequence  of human 
cytokeratin  15  as deduced from cDNA clone pKH15 ~ and 
the 479-bp Kpnl fragment of the genomic clone ~KH152 en- 
compasses '~1.7 kb (Fig. 7). S1 nuclease mapping (data not 
shown) indicated that the transcription started at the KpnI 
site at  the start of the sequence presented in Fig.  7,  most 
probably at position 4, thus defining a short 58-nucleotide- 
long, 5'-nontranslated region. The cDNA terminates 23 bp 
downstream of a typical polyadenylation signal with a short 
poly-(A) stretch. 
The coding region of cytokeratin 15 defines a polypeptide 
of 456 amino acids,  amounting to a total mol wt of 49,170 
including the initial methonine which is probably lost after 
translation.  This value is in agreement with that estimated 
from SDS-PAGE analyses (Mr 50,000;  cf.  ll,  24,  65,  96). 
The 96-amino acid-long head domain displays features com- 
Figure 6. Autoradiographs of Northern blot hybridization experi- 
ments  using riboprobes  derived  from  the  BglI-truncated clone 
pKH15 ~.  10 lag of total RNA was applied, except for lanes 2 and 
3 (50 lag of total RNA) and lanes 1 and 7 which contain 2 and 5 
lag of poly(A)+-RNA, respectively. RNA was extracted from hu- 
man A-431 cells (lanes 1 and 7), liver (lane 2), epidermis (lane 3), 
SV-40-transformed fibroblasts  (lane 4),  MCF-7 cells  (lane 5), 
Detroit-562 cells (lane 6), esophagus (lane 8), and colon (lane 9). 
Note intense reaction with a  "~l.9-kb RNA in A-431 cells, epi- 
dermis, and esophagus. A weak but clearly detectable hybridization 
signal was also seen in Detroit-562 cells after prolonged exposure 
(not shown). Bars indicate rRNAs as in Fig. 2. 
mon to various cytokeratins (cf. 2) such as an amino-terminal 
SvSSsRFsS  as  cluster  of hydroxyamino acids,  the  motif  A  A  V 
well as several glycine-rich oligopeptide repeats (Figs. 7 and 
8). The very high glycine content (44.3%) in this region is 
particularly noteworthy. 
The structure predicted for the a-helical rod domain is in 
agreement with the basic IF conformation (for reviews, see 
31,  82,  93).  The three coiled-coil domains defined by the 
heptad repeats are interrupted by two spacer sequences, and 
the "consensus sequence" TYR(X)LLEG is recognized at the 
end of this domain. 
The tail region contains only a short stretch rich in glycine 
and serine. In contrast to cytokeratin 4 a heptapeptide motif 
DGQVVSS  similar  to  the  hallmark  sequence  DGKvLVS~ 
mentioned above, which shows a striking resemblance to the 
core motif of calcium-binding  proteins of the "EF-finger" 
type (19),  is located close to the carboxy terminus. 
Comparison of the amino acid sequence of cytokeratin 15 
with those of other proteins identified this polypeptide as a 
member of the acidic (type I) subfamily of cytokeratins (e.g., 
36, 83). It shows a particularly close relationship (Fig. 8) to 
the human cytokeratin  14 (76%  identity in the rod region; 
62%  overall identity; 36,  61), and murine Mr 47,000 cyto- 
keratin (85 % identical positions in the rod domain; 51) and 
the amphibian cytokeratin A~  of the XK81 gene subfamily 
(44, 63). Surprisingly, it also shows a high similarity (74% 
identical positions in the rod) with the simple epithelial type 
I cytokeratin 19 from cow (2). 
Leube et al.  Molecular  Characterization  of Cvtokeratins  4 and 15  1255 1  GGT ACC T CC T GCCAGCACCT C T T GGG T T TGC T GAGAACTCACGGGC TCCAGC T ACC T GGCCAT GACCACCACAT T T C T GCAAAC T T C "f T C 
1  M  T  T  T  F  L  Q  T  S  S 
91  C T CCACC  T T T  GGGGGT  GGC  TCAACCCGAGGGGGT  TCCC  TCC T GGC  TGGGGGAGGT  GGCT T T GGTGGGGGGAGTC  TC T C TGGGGGAGG  r GG 
11  S  T  F  G  G  G  S  T  R  G  G  S  L  L  A  G  G  G  G  F  G  G  G  S  L  S  G  G  G  G 
181  AAGC~G~GTAT~T~AGCTTCTTCTGCTAGGTTTGT~T~TTCAGGGTCAGGAGG~GGATATGGGGGTGGCATGAGGGTCTGTGG~TTTGG 
41  S  R  S  I  S  A  S  S  A  R  F  V  S  S  G  ~  G  G  G  Y  G  G  G  M  R  V  C  G  F  G 
2;"I  TGGAGGGGCTGGTAGTGT  T  T  TCGGTGGAGGCT  TTGGAGGGGGCGT  TGGTG~GGT  T  T  TGGTGGqr  GGC  T  T  TGGTGGTGGCP-.~-TGGu  GGT  C  T 
71  G  G  A  G  $  V  F  G  G  G  F  G  G  G  V  G  G  G  F  G  G  G  F  G  G  G  O  G  G  L 
361  CCTCTCTGG~AATGAGAAAATTACcATGcAGAACCTCAATGAcCGCcTGGcCTCcTAc~TGGA~AAGGTA~GTGcCCTGGAGGAGGCCAA 
101  L  5  G  N  E  K  I  T  M  Q  N  L  N  D  R  L  A  S  Y  L  D  K  V  R  A  L  E  IE  A  N 
451  T GC T GACC T GGAGG T GAAGAT CCAT GAC T GG T ACCAGAAGCAGACCC CAGCCAGCCCAGAA T GCGAC T ACAGCCAAT ACT T CAAGACCA T 
131  A  D  L  E  V  K  I  H  D  W  Y  Q  K  Q  T  P  A  S  P  E  C  D  Y  S  Q  Y  F  K  T  I 
541  TGAAGAGCTCCGGGACAAGATCATGGCCAC~A~CATCGA~AACTCCCGGGTCATC~TGGAGATCGA~AATGCCAGGCTGGCTGCGGACGA 
161  E  E  L  R  D  K  I  M  A  T  T  I  O  N  S  R  V  I  L  E  I  D  N  A  R  L  A  A  D  D 
631  C T T CAGGCT CAAGTATGAGAATGAGCTGGCCCTGCGCCAGGGCGT  TGAGGCTGACATCAACGGCT  TGCGCCGAGTCC TGGATGAGC TGAC 
191  F  R  L  K  Y  E  N  E  L  A  L  R  Q  G  V  E  A  D  I  N  G  L  R  R  V  L  D  E  L  T 
721  CC  T GGCCAGGAC T GAC C TGGAGAT GCAGA TCGAGGGCC TGAATGAGGAGC TAGCC TACCTGAAGAAGAACCACGA~.GAGGAGA  T GAAGGA 
221  L  A  R  T  D  L  E  M  Q  I  E  G  L  N  E  E  L  A  Y  L  K  K  N  H  E  E  E  M  K  E 
81 1  GTTCAGCAGCCAGCTGGCCGGCCAGGT~AATGTGGAGATGGA~GCAGCACCGGGTGTGGACCTGACCCGTGTGCTGGCAGAGATGAGGGA 
251  F  S  S  Q  L  A  G  Q  V  N  V  E  M  D  A  A  P  G  V  D  L  T  R  V  L  A  E  M  R  E 
801  GCAGT ACGAGGCCAT GGCGGAGAAGAACCGCCGGGA TG T CGAGGCC T GGT T C T T CAGCAAGAC T GAGGAGCTGAACAAAGAGGT GGCC T C 
~81  Q  Y  E  A  M  A  E  K  N  R  R  D  V  E  A  W  F  F  S  K  T  E  E  L  N  K  E  V  A  S 
991  CAACACAGAAA  T GA T CCAGACCAGCAAGACGGAGA T CACAGACC T GAGACGCACGAT GCAGGAGC T GGAGA T CGAGC T GCAGT CC  CAGC T 
311  N  T  E  M  I  Q  T  S  K  T  E  I  T  D  L  R  R  T  M  Q  E  L  E  I  E  L  Q  S  Q  L 
1081  CAGCATGAAAGCTGGGCTGGAGAA•TCACTGGCCGAGACAGAGTG•CG•TATGCCA•GCAG•TG•AGCAGATC•AGGGGCT•ATTGGTGG 
941  S  M  K  A  G  L  E  N  S  L  A  E  T  E  C  R  Y  A  T  Q  L  Q  Q  I  Q  G  L  I  G  G 
11T1  CC  T GGAGGCCCAGC TGAGTGAGC TCCGA TGCGAGAT GGAGGC TCAGAACCAGGAG TACAAGA'r GC TGC T TGACATAAAGACACGGC  T GGA 
3T1  L  E  A  Q  L  S  E  L  R  C  E  M  E  A  Q  N  Q  E  Y  K  M  L  L  D  I  K  T  FI  L  E 
1261  GCAGGAGATCG•TA•TTA••GCAG•CTGCT•GAGGG•CAGGATGCCAAGATGG•TGGCATTGGcAT•AGGGAAGCCT•TTCAGGAGGTGG 
401  Q  E  I  A  T  Y  R  S  L  L  E  G  Q  ~  D  A  K  M  A  G  I  G  I  R  E  A  S  S  G  G  G 
1351  TGGTAGCAGCAGCAAT  T TCCACATCAATGTAGA.~.GAGTCAGTGGA]"  GGACAGGT GGT T TCT TCCCACAAGAGAGAAATCTAAGTGT  C TAT 
431  G  S  S  S  N  F  H  I  N  V  E  E  S  V  D  G  Q  v  V  S  S  H  K  R  E  I 
1441  TG~AGGAGAAACGT~cCTTGCCA~TCCCCAcT~TCATCAGGCCAAGTGGAGGA~TGGCCAGAGGGcCTG~ACATGCAAACTCCAGTCCCT 
1531  GCC T TCAGAGAGC TGAAAAGGGTCCC T CGGTC T T T TAT T TCAGGGC T T "r GCATGCGC TCT AT TCCCCC TC TGCCTCTCCCCACCT  TC TT T 
1621  GGAGCAAGGAGATGCAGCTGTAT  TGTGTAACAAGC TCAT T TGTACAGTGTC TGT TCATGTAATAAAGAAT  TAC ]" T T TCCTT T T GCAA.&TA 
1 ~' 11  A~,,~,AAAAAAAAAA 
Figure 7. Nucleotide sequence and 
deduced amino acid sequence of 
human  cytokeratin  15.  The  se- 
quence 5' of the triangle was de- 
rived  from the KpnI/KpnI frag- 
ment of the genomic clone LKHI52 
whereas the sequence 3' of the tri- 
angle  was  determined  from  the 
cDNA clone pKHI5 ~, which was 
confirmed by sequencing the ge- 
nomic clone. Asterisk denotes the 
stop codon. The end of the ct-hel- 
ical  coiled-coil  rod  domain  is 
demarcated by an arrow,  the ca- 
nonical  polyadenylation  site  is 
underlined. The Bgll site used for 
truncation prior to  in vitro tran- 
scription is overlined. The broken 
line denotes the region represented 
by  the  synthetic  polynucleotide 
cloned in pKHI5:. 
H14  MTTCSRQFT~$SMK~S~G~G~G~GA~SSR~SSVLAG~SCRAPNTYGGGL$~$SRF-S~GAYGL~GGYGGG~SSSSSSFGSGFGGGYG 
H15  MTTTFLQ  TS$STFGGGSTRGGSLLAGGGGFGGGSLSGGGGSRS  -  ISASSARFV$SGS  ....  GGQYGQGMRVCG-  FGGGAGSVFG 
XK81  .......................  MrSYRSSSASYYSGSSSKGGFGSRSLAGSNSYGGSSFGAGrSS 
H  .IT cla  ~o~  [-Clb 
H14  GGLGAGLGQGFQGGFAGG-DGLLVGSEKVTMQNLNDRLASYLDKVRALEEANADLEVKI  YQRQRPA  -E  I  KDYSPYFKT  IEDLRN 
H15  GQFGGQVGGGFGGGFGQQDGGLLSGNEKITMQNLNDRLAIYLDKVRALEEANADLEVKIHDWYQKQTPA-  SPECDYSQYFKTIEELRI) 
XK81  GVGSGFSSSGGNFAMAEAASsSFG•NEKHAM•NLNDR•A•YLEK•R•L•A•NS•LEGK•RN•YDKQSDAGLGAGSKDY•KYFE  I  IAELRN 
.  Clb 
H14  K~L]AT~DNANv~LQ~DlARL~ADDFR~KYETELNLRMS~EAD~N~LRR~LDELT~ARADLEMQ~ESLKEELAYLKKNHEEEMNAtRGQV 
H15  K•MATT•DN•R••LE••••RL•AD•FRLKYENELALRQG•EAD•N•LRR•LDELTLARTDLEMQ•EGLNEELAYLKKNHEEEMKEFSSQ• 
XK81  K~RAAT~DNA~vTL~N&~LA~FRLKFENEL&LR~S~EG~S~GLRR~LDEL~LARGD~E~Q~ESLTEEL~YLKKNHEEEMSHAK~QS 
r 
C2 
H14  GGDv•vEMDAAP•u 
H15  A~Q~NvE~AA~Q~LTN~LAEmREQYEAMAEKNRRD~EA~FFSKTEELNKE~SN~EM[QT$KTE~TDLRRTMQELE|ELQ$QL$MKAG 
XK81  AGK~s~EMDAAL~LTS~LNNgRADYE~LAEKNRRDAEL~FNQKSGELKKEIS~GVEQVQA$KSE~TELKRSLQSLE~ELQ~QLAMKQS 
-----.-  C2  -.]  T 
/ 
m 
H14  LENSL  E ETK  GRYCMQLAQ  I  QEM  I  QS  VEEQL  AOLRCEMEQQNQEYK  r  L  LDVKTRLEQE  I  ATYRR  L  LEGE  DAH  L  SSSQFSSGSOSSRDVT$$ 
H15  LENSLAETE  CRYA  TQLQQ  I  QG  L  IGGLEAQLSE  LRGEMEAQNQEYKMLLD  I  KTRLEQE  I  ATYRS  LLEGQDAKMAG  I  G  I  R  E  A$SGGGG  -$S 
XK81  VEGNLNELQGFYSSQLQQIQNT  IGSLEEQL  L0  I  RSDMEHQNTEYKL  LLD  IKTRLEME  IQTYRRLLEGE  [  GQV  T T  VAN  T SSVF  SK  T ESSST 
H14  IRQIR[K  --  VMDVHDGKVVSTHEOVLRTKN 
~lS  $NFHIN-  --  VEESVDGQVVIIHK-  REI- 
XK81  STTRTRMVKTIVEEVVOQKVVII-  --  RVE- 
Figure 8. Comparison of the amino acid sequence of human cytokeratin 15 (H 15) with those of human cytokeratin 14 (H 14; 61) and the 
Xenopus laevis cytokeratin XK81  A,  (XK81;  44,  63).  Residues which are  identical to human cytokeratin  15 are printed in bold letters. 
The positions of the a-helical coils in rod domains are designated Cla, Clb, and C2 (arrows). H, head region,  T, tail domain. Sequence 
conservation of the three proteins is high in the rod domain but restricted to certain oligopeptide motifs in the tail and head region. 
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as Determined by In Situ Hybridization 
To examine the expression of the genes encoding cytokera- 
tins 4 and 15 in complex stratified tissues, we prepared radio- 
actively  labeled  antisense  RNA  probes and  used  them  for 
hybridization  in situ.  For example,  we show the results ob- 
tained  for esophagus.  Intense reactions  were  seen  for both 
mRNAs (Figs. 9 and 10),  in particular when compared to the 
much weaker hybridization signals obtained with the probes 
for the simple epithelial  type cytokeratins  8  and  18 (cf.  9). 
In autoradiographs using the cytokeratin 4 mRNA probe the 
label was spread over most of the epithelial cell  layers (Fig. 
9,  a  and  b) but showed,  in  some regions,  a  reduction  over 
the basal cell layer (Fig. 9 c). Interestingly, in some epithelial 
regions the silver grain density was also drastically reduced 
in the  upper,  i.e.,  adluminal  strata  (Fig.  9  c). 
The antisense riboprobe for cytokeratin  15 mRNA always 
yielded uniform hybridization in all cell layers of all samples 
examined (Fig.  lO, a and b), indicative of the presence of this 
mRNA  in  the  entire  epithelium,  including  the  basal  cell 
layer. The same signal distribution  was seen after hybridiza- 
tion with the synthetic polynucleotide probe representing the 
3'-noncoding  region  (Fig.  l0  c).  Hybridization  reactions 
were  also  seen  over ductal  epithelia  traversing  the  lamina 
propria,  particularly  for cytokeratin  15  mRNA  (Fig.  lO b, 
arrow). 
Similar results were obtained for other stratified epithelia 
such as exocervix (data not shown).  Neither for cytokeratin 
4 nor for cytokeratin  15 mRNA have we noticed regional in- 
traepithelial  heterogeneities  of the  kind  recently  described 
for murine  tongue  mucosa (76). 
Discussion 
In this study we have introduced and characterized two DNA 
clones encoding cytokeratins 4 and  15 which are both typical 
for  certain  differentiation  programs  of stratified  epithelia. 
Notably, cytokeratin 4,  which usually occurs in heterotypic 
"pair"  complexes  with  cytokeratin  13  (11, 23,  38,  87),  has 
been described as a hallmark of a developmental line for cer- 
tain  squamous  nonepidermal  epithelia  ("esophageal  type of 
differentiation" sensu  11,  12,  87). 
The general molecular features of these two polypeptides 
are  similar  to  those  of other  type  II (polypeptide 4)  and  I 
(polypeptide  15)  cytokeratins.  Interestingly,  both  cytokera- 
tins  present  a  tail  region  with  a  comparatively  low glycine 
content,  unlike many other cytokeratins from squamous epi- 
Figure 9. Microscopic autoradiographs of frozen sections of human 
esophagus,  showing  the  differential  distribution  of cytokeratin 4 
mRNA  after  hybridization  with  3H-labeled  transcripts  of  the 
Hindlll-linearized clone pKH4  ~. Symbols used are the same as in 
Fig.  1.  (a,  b) A  region of the upper esophagus,  showing a silver 
grain  distribution  that  is  nearly  even  over most  of the  epitheli- 
um  (E),  with  somewhat  lower density  over the  basal  cell  layer 
(brackets; broken line denotes basal lamina). (a) Survey autoradio- 
graph  (dark  field  illumination);  (b)  higher  magnification  (bright 
field photograph).  (c)  Dark field  illumination picture of a section 
from lower esophagus (in the transition zone to the stomach), show- 
ing distinctly lower concentrations of hybridization signals in the 
basal cell  layers and in the upper cell  layers (L,  lumen).  Note the 
absence of labeling  over protrusions of the  lamina propria (LP). 
Bars:  (a and  c) 250  I.tm; (b) 25  ~tm. 
Leube et al.  Molecular  Characterization  of Cytokeratins  4 and 15  1257 Figure 10. Microscopic autoradiograph of frozen sections of human esophagus,  illustrating  the homogeneous distribution of cytokeratin 
15 mRNA after hybridization with cRNA probes derived from the BglI-truncated clone pKH15 ~  (a, b) and the 5'-end-labeled, 3'-specific 
polynucleotide (c). Symbols are as in Fig. 9. (a) Bright field micrograph showing the rather evenly spread label obtained after hybridization 
with the [a-32p]UTP-labeled cRNA probe for cytokeratin 15. (b) Dark field survey autoradiograph of a section hybridized with antisense 
RNA of pKH15 z. Note the even signal  distribution over the entire stratified  epithelium and in the glandular ducts (arrow in b). (c) Dark 
field illumination of a section of the lower esophagus after hybridization with the [~/-32p]ATP-labeled polynucleotide complementary to 
residues  1606-1680  (for details,  see Results).  Bars:  (a) 25  Ixm; (b and c) 250 I.tm. 
thelia such as various epidermal cytokeratins of human,  bo- 
vine,  murine and amphibian origin  (37,  39,  45,  47,  54,  79, 
82,  83,  88).  The probes specific for the 3'-noncoding region 
of both cytokeratins,  which react specifically with only one 
mRNA  species  in  the  various  cells  and  tissues  examined, 
should  be  valuable  in  studying  gene  expression  programs 
related  to  the  formation  of  stratified  epithelia,  including 
squamous  metaplasia of simple epithelia,  as well  as in the 
The Journal of Cell Biology, Volume  106,  1988  1258 characterization of various types of squamous cell carcinomas 
which may be distinguished by the presence or absence of 
cytokeratin 4 and/or cytokeratin 15 (for gel electrophoretic 
and immunocytochemical  analyses see references 4, 5, 8, 31, 
35, 64-67,  91). 
The immunocytochemical results of the present study, as 
well as previous reports on the distribution of cytokeratin 
4 in stratified tissues (22, 72, 91; see there also for similar 
data with cytokeratin 13 antibodies), have shown reduced or 
even absent reactions in the basal cell layer. This is reminis- 
cent of  the negative reactions of  basal cell layers of epidermis 
obtained with antibodies to certain epidermal components, 
(10, 41, 47, 55, 81, 87, 95). This has usually been interpreted 
to mean that the synthesis of these proteins is initiated only 
during  or  after  commitment to  vertical,  i.e.,  suprabasal 
differentiation and is related to the transition of the specific 
cell from the basal to the suprabasal compartment (cf. 30). 
However,  our in situ hybridizations show that mRNA for 
both stratification-related cytokeratins can be synthesized in 
all layers of esophagus, including the basal layer. Clearly, the 
gene  encoding cytokeratin  15  is  actively transcribed  and 
cytokeratin 15 mRNA accumulated already in the basal cell 
layer.  For cytokeratin 4,  mRNA can also be seen in basal 
cells of some esophageal regions whereas other regions pres- 
ent only with low levels of mRNA in the basal compartment, 
which seems to correspond to the absence of immunocyto- 
chemically detectable amounts of this protein in basal layers 
of certain epithelia (this study; 22, 91). The reasons for the 
observed regional heterogeneities of cytokeratin 4  expres- 
sion in the basal cell layer as well as in adluminal cell layers 
are not known. 
These results, together with those obtained for cytokera- 
tins 8,  14, and 18 (9),  also indicate that at least in certain 
stratified epithelia commitment to suprabasal translocation 
and vertical cell differentiation can already commence in the 
basal cell layer and that the genes for both kinds of cytokera- 
tins, the simple epithelial ones and the stratification-related 
ones, can be coexpressed, at least in certain regions. This 
also demonstrates that proliferation and expression of supra- 
basal marker proteins do not necessarily exclude each other. 
These conclusions also receive support from observations of 
the onset of synthesis of cytokeratin 4 in cell clusters of cer- 
tain glands and glandular ducts (this study; 91), in individual 
cells of various simple and complex epithelia such as en- 
docervix  (22)  and bronchial  epithelium (91), which  may 
reflect early changes toward  squamous metaplasia, and in 
certain layers of fetal human epidermis (92).  Noteworthy in 
this context are also observations that,  in certain cells of 
squamous and transitional cell carcinomas, the simple epi- 
thelial  cytokeratins 8  and  18  are  often coexpressed  with 
stratification-related  ones  such  as  cytokeratins  4-6  and 
13-17, although often only focally (cf. 22, 91). It will be im- 
portant to examine, by in situ hybridization, whether such 
cellular heterogeneities are only due to immunocytochemical 
phenomena such as epitope masking (for examples with IF 
proteins, see 14, 16, 21, 26, 95), or whether it is also evident 
at the mRNA level. 
The  observation  of  coexpression  of  simple  epithelial 
cytokeratins and cytokeratins 4 and 15 in basal cells of certain 
stratified tissues also raise the question of the nature of the 
cytokeratin complexes present in these cells. It is well con- 
ceivable that these polypeptides, when present at low con- 
centrations, as this is probably the case in the basal cells, can 
form heterotypic complexes with each other as well as with 
other complementary partners,  as  it has  been  shown by 
recombination of purified cytokeratins in vitro (18, 38) and 
by integration of mRNAs or cloned cytokeratin genes into 
cultured epithelial cells (25,  33).  The possible combination 
of cytokeratin 4 with type I cytokeratins other than cytokera- 
tin  13  is also supported by reports of cells in which only 
cytokeratin 4 but not cytokeratin 13 has been detected such 
as amnion epithelium (75), certain cells of cornea and pan- 
creatic ducts (91), some squamous cell carcinomas (5,  35, 
65), and fetal epidermis (92).  Vice versa, a number of cul- 
tured cell  lines and squamous cell carcinomas synthesize 
considerable amounts of cytokeratin 13 without detectable 
cytokeratin 4 (1, 67, 77, 78). This raises the question of the 
coordinate regulation of "pairs" of cytokeratins in some cell 
types as opposed to the noncoordinated synthesis of these 
polypeptides in other cells. The new cDNA probes described 
in this paper will hopefully contribute to the identification of 
the level of regulation at which such coordinations and dis- 
proportionate  syntheses  take  place,  also  with  respect  to 
changes of expression due the environment (15, 50,  89). 
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